Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYNJ2 | O15056 | 3/20 | 0.87 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.49 |
| ▸ | GRK2 | P25098 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albiflorin SCHEMBL21164770 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL22648992 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL21315817 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL15235363 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL29500192 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL24008597 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL21702839 | 1.00 | SYNJ2 (0.87) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Albiflorin SCHEMBL13387630 | 0.98 | SYNJ2 (0.85) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| SCHEMBL21325290 | 0.94 | SYNJ2 (0.77) | SYNJ2SLC22A1GRK2MAOBPTPN1 | |
| Paeonivayin SCHEMBL18504853 | 0.93 | SYNJ2 (1.00) | SYNJ2SLC22A1GRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031496-A | Use of paeoniflorin for adjuvant treatment of cancer | 北京中医药大学 | 2026-05-15 | — | — | CN | claimed |
| US-12616709-B2 | Pharmaceutical composition for treating sepsis and use thereof | TIANJIN CHASE SUN PHARMACEUTICAL CO., LTD. (CN) | 2026-05-05 | — | — | US | claimed |
| US-20260021153-A1 | TRADITIONAL CHINESE MEDICINE FORMULATION FOR PREVENTING AND TREATING CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) | CENTRE FOR CHINESE HERBAL MEDICINE DRUG DEVELOPMENT LTD (CN) | 2026-01-22 | — | — | US | claimed |
| CN-120131683-A | Antidepressant composition and preparation method thereof | 天津中医药大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120114520-A | Blood-nourishing, channel-warming and vein-relaxing traditional Chinese medicine composition for treating peripheral neuropathy and preparation method and application thereof | 浙江中医药大学附属第二医院(浙江省新华医院) | 2025-06-10 | — | — | CN | claimed |
| US-20250177467-A1 | COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS | UNIV YALE (US) | 2025-06-05 | — | — | US | claimed |
| CN-120053522-A | Application of traditional Chinese medicine composition in preparation of medicine for relieving oxaliplatin chemotherapy side reaction | 江南大学附属医院 | 2025-05-30 | — | — | CN | claimed |
| CN-120053521-A | White peony root extract and extraction method and application thereof | 宁波立华制药有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120037281-A | Use of Chinese medicinal material extract for preparing medicine or non-medicine composition for improving mitochondrial activity | 台湾粒线体应用技术股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119970844-A | Preparation process of total glucosides of paeony extract, detection method and application thereof | 宁波职业技术学院 | 2025-05-13 | — | — | CN | claimed |
| CN-1332651-C | Wuji dripping pill for treating liver and stomach diseases and its preparing method | ZHENGDA LUZHOU MED SCIENCE (CN) | 2007-08-22 | — | — | CN | claimed |
| EP-1776129-A1 | THE USE OF PAEONIA AND EXTRACTS THEREOF WITH GROWTH PROMOTING ACTIVITY IN VETERINARY MEDICINE AND ZOOTECHNICS | INDENA S.p.A. (IT) | 2007-04-25 | — | — | EP | claimed |
| WO-2007038610-A2 | USE OF NATURAL PRODUCTS FOR TREATMENT OF NEUROLOGICAL DISORDERS | PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) | 2007-04-05 | — | — | WO | claimed |
| WO-2006012999-A1 | THE USE OF PAEONIA AND EXTRACTS THEREOF WITH GROWTH PROMOTING ACTIVITY IN VETERINARY MEDICINE AND ZOOTECHNICS | INDENA S.P.A. (IT) | 2006-02-09 | — | — | WO | claimed |
| CN-1682829-A | Wuji dripping pill for treating liver and stomach diseases and its preparing method | ZHENGDA LUZHOU MED SCIENCE (CN) | 2005-10-19 | — | — | CN | claimed |
| CN-1213762-C | Medicine for invigorating kidney, promoting blood circulation and promoting skeleton formation and its prepn | XIN YAOLU (CN) | 2005-08-10 | — | — | CN | claimed |
| US-20030232102-A1 | Total glycosides of paeony, method to prepare the same and uses thereof | ZHAO XINXIAN (CN) | 2003-12-18 | — | — | US | claimed |
| CN-1403113-A | Medicine for tonifying kidney, promoting blood circulation and generating bone and preparation method thereof | XIN YAOLU (CN) | 2003-03-19 | — | — | CN | claimed |
| WO-2002085395-A1 | TOTAL GLYCOSIDES OF PAEONY, METHOD TO PREPARE THE SAME AND USES THEREOF | SANJIU MEDICAL & PHARMACEUTICAL CO., LTD. (CN) | 2002-10-31 | — | — | WO | claimed |
| CN-1077386-A | A kind of Chinese patent medicine for the treatment of angina pectoris | PLA AIRFORCE GENERAL HOSPITAL (CN) | 1993-10-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021153-A1 | TRADITIONAL CHINESE MEDICINE FORMULATION FOR PREVENTING AND TREATING CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) | VIP, RDX, SI | SYNJ2 1978/4885SLC22A1 2433/4885GRK2 880/4885 |
| US-20030232102-A1 | Total glycosides of paeony, method to prepare the same and uses thereof | UGT2B7, UGT1A7, CYP3A7 | SYNJ2 1443/4885SLC22A1 1039/4885GRK2 2555/4885 |
| US-12616709-B2 | Pharmaceutical composition for treating sepsis and use thereof | CYP3A43, CYP4A22, SF1 | SYNJ2 1279/4885SLC22A1 751/4885GRK2 2551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.